These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1648879)

  • 1. Lymphomas following cardiac transplantation. Case report and review of the literature.
    Sklarin NT; Dutcher JP; Wiernik PH
    Am J Hematol; 1991 Jun; 37(2):105-11. PubMed ID: 1648879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-induced lymphoma in a cardiac transplant recipient.
    Dummer JS; Bound LM; Singh G; Atchison RW; Kapadia SB; Ho M
    Am J Med; 1984 Jul; 77(1):179-84. PubMed ID: 6331161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
    Hunt BJ; Thomas JA; Burke M; Walker H; Yacoub M; Crawford DH
    Transplantation; 1996 Sep; 62(6):869-72. PubMed ID: 8824493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
    Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M
    Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature.
    Raut A; Huryn J; Pollack A; Zlotolow I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):436-41. PubMed ID: 11027379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Signification of Epstein-Barr virus detection in the cerebrospinal fluid of a patient with human immunodeficiency virus related Burkitt lymphoma].
    Jennane S; Mahtat el M; Konopacki J; Foissaud V; Souleau B; Malfuson JV; De Revel T
    Ann Biol Clin (Paris); 2013; 71(3):341-4. PubMed ID: 23747673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases.
    Gong JZ; Stenzel TT; Bennett ER; Lagoo AS; Dunphy CH; Moore JO; Rizzieri DA; Tepperberg JH; Papenhausen P; Buckley PJ
    Am J Surg Pathol; 2003 Jun; 27(6):818-27. PubMed ID: 12766587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML.
    Huang Q; Popplewell L; Lu Y; Slovak ML; Forman SJ
    Bone Marrow Transplant; 2010 Jan; 45(1):191-4. PubMed ID: 19430500
    [No Abstract]   [Full Text] [Related]  

  • 9. Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses.
    Hanto DW; Birkenbach M; Frizzera G; Gajl-Peczalska KJ; Simmons RL; Schubach WH
    Transplantation; 1989 Mar; 47(3):458-64. PubMed ID: 2538015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Trends and Alternative Scenarios in EBV Research.
    Minarovits J; Niller HH
    Methods Mol Biol; 2017; 1532():1-32. PubMed ID: 27873264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors.
    Orentas RJ; Lemas MV; Mullin MJ; Colombani PM; Schwarz K; Ambinder R
    J Hematother; 1998 Jun; 7(3):257-61. PubMed ID: 9621259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
    Xicoy B; Ribera JM; Esteve J; Brunet S; Sanz MA; Fernández-Abellán P; Feliu E
    Leuk Lymphoma; 2003 Sep; 44(9):1541-3. PubMed ID: 14565657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
    Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 16. Virology and immune mechanisms.
    Merigan TC
    Cancer; 1981 Mar; 47(5 Suppl):1091-4. PubMed ID: 6263441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus, malaria and endemic Burkitt lymphoma.
    Velavan TP
    EBioMedicine; 2019 Jan; 39():13-14. PubMed ID: 30584007
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant lymphomas associated with immunodeficiency states.
    Biemer JJ
    Ann Clin Lab Sci; 1990; 20(3):175-91. PubMed ID: 2188564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
    Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S
    Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphomas.
    Gandhi MK
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.